430 related articles for article (PubMed ID: 8396718)
1. Dual coupling of cloned human 5-hydroxytryptamine1D alpha and 5-hydroxytryptamine1D beta receptors stably expressed in murine fibroblasts: inhibition of adenylate cyclase and elevation of intracellular calcium concentrations via pertussis toxin-sensitive G protein(s).
Zgombick JM; Borden LA; Cochran TL; Kucharewicz SA; Weinshank RL; Branchek TA
Mol Pharmacol; 1993 Sep; 44(3):575-82. PubMed ID: 8396718
[TBL] [Abstract][Full Text] [Related]
2. Alniditan, a new 5-hydroxytryptamine1D agonist and migraine-abortive agent: ligand-binding properties of human 5-hydroxytryptamine1D alpha, human 5-hydroxytryptamine1D beta, and calf 5-hydroxytryptamine1D receptors investigated with [3H]5-hydroxytryptamine and [3H]alniditan.
Leysen JE; Gommeren W; Heylen L; Luyten WH; Van de Weyer I; Vanhoenacker P; Haegeman G; Schotte A; Van Gompel P; Wouters R; Lesage AS
Mol Pharmacol; 1996 Dec; 50(6):1567-80. PubMed ID: 8967979
[TBL] [Abstract][Full Text] [Related]
3. Coupling of an endogenous 5-HT1B-like receptor to increases in intracellular calcium through a pertussis toxin-sensitive mechanism in CHO-K1 cells.
Dickenson JM; Hill SJ
Br J Pharmacol; 1995 Dec; 116(7):2889-96. PubMed ID: 8680721
[TBL] [Abstract][Full Text] [Related]
4. Native 5-HT1B receptors expressed in OK cells display dual coupling to elevation of intracellular calcium concentrations and inhibition of adenylate cyclase.
Zgombick JM; Branchek TA
Naunyn Schmiedebergs Arch Pharmacol; 1998 Nov; 358(5):503-8. PubMed ID: 9840417
[TBL] [Abstract][Full Text] [Related]
5. Functional characterization of the recombinant human 5-hydroxytryptamine7(a) receptor isoform coupled to adenylate cyclase stimulation.
Adham N; Zgombick JM; Bard J; Branchek TA
J Pharmacol Exp Ther; 1998 Nov; 287(2):508-14. PubMed ID: 9808674
[TBL] [Abstract][Full Text] [Related]
6. Pharmacological characterizations of recombinant human 5-HT1D alpha and 5-HT1D beta receptor subtypes coupled to adenylate cyclase inhibition in clonal cell lines: apparent differences in drug intrinsic efficacies between human 5-HT1D subtypes.
Zgombick JM; Schechter LE; Adham N; Kucharewicz SA; Weinshank RL; Branchek TA
Naunyn Schmiedebergs Arch Pharmacol; 1996; 354(3):226-36. PubMed ID: 8878051
[TBL] [Abstract][Full Text] [Related]
7. Prostaglandin receptors in NIH 3T3 cells: coupling of one receptor to adenylate cyclase and of a second receptor to phospholipase C.
Gusovsky F
Mol Pharmacol; 1991 Nov; 40(5):633-8. PubMed ID: 1658602
[TBL] [Abstract][Full Text] [Related]
8. Pharmacologic evidence for 5-HT1A receptors associated with human retinal pigment epithelial cells in culture.
Nash MS; Osborne NN
Invest Ophthalmol Vis Sci; 1997 Feb; 38(2):510-9. PubMed ID: 9040484
[TBL] [Abstract][Full Text] [Related]
9. Pharmacological characterization of the "silent" 5-hydroxytryptamine1B-like receptors of rabbit ear artery.
Movahedi H; Purdy RE
J Pharmacol Exp Ther; 1997 Nov; 283(2):653-60. PubMed ID: 9353382
[TBL] [Abstract][Full Text] [Related]
10. Multiple phosphorylation sites are required for pathway-selective uncoupling of the 5-hydroxytryptamine1A receptor by protein kinase C.
Lembo PM; Albert PR
Mol Pharmacol; 1995 Dec; 48(6):1024-9. PubMed ID: 8848001
[TBL] [Abstract][Full Text] [Related]
11. Phorbol ester-induced augmentation and inhibition of epinephrine-stimulated adenylate cyclase in S49 lymphoma cells.
Johnson JA; Goka TJ; Clark RB
J Cyclic Nucleotide Protein Phosphor Res; 1986; 11(3):199-215. PubMed ID: 3020100
[TBL] [Abstract][Full Text] [Related]
12. Agonistic properties of alniditan, sumatriptan and dihydroergotamine on human 5-HT1B and 5-HT1D receptors expressed in various mammalian cell lines.
Lesage AS; Wouters R; Van Gompel P; Heylen L; Vanhoenacker P; Haegeman G; Luyten WH; Leysen JE
Br J Pharmacol; 1998 Apr; 123(8):1655-65. PubMed ID: 9605573
[TBL] [Abstract][Full Text] [Related]
13. Ca2+ inhibition of beta-adrenergic receptor- and forskolin-stimulated cAMP accumulation in C6-2B rat glioma cells is independent of protein kinase C.
Debernardi MA; Munshi R; Brooker G
Mol Pharmacol; 1993 Mar; 43(3):451-8. PubMed ID: 8383803
[TBL] [Abstract][Full Text] [Related]
14. 5-Hydroxytryptamine2A receptors expressed in rat renal mesangial cells inhibit cyclic AMP accumulation.
Garnovskaya MN; Nebigil CG; Arthur JM; Spurney RF; Raymond JR
Mol Pharmacol; 1995 Aug; 48(2):230-7. PubMed ID: 7651356
[TBL] [Abstract][Full Text] [Related]
15. Human gene S31 encodes the pharmacologically defined serotonin 5-hydroxytryptamine1E receptor.
Zgombick JM; Schechter LE; Macchi M; Hartig PR; Branchek TA; Weinshank RL
Mol Pharmacol; 1992 Aug; 42(2):180-5. PubMed ID: 1513320
[TBL] [Abstract][Full Text] [Related]
16. A1 and A2 adenosine receptor modulation of contractility in the cauda epididymis of the guinea-pig.
Haynes JM; Alexander SP; Hill SJ
Br J Pharmacol; 1998 Oct; 125(3):570-6. PubMed ID: 9806342
[TBL] [Abstract][Full Text] [Related]
17. The m2 muscarinic acetylcholine receptors are coupled to multiple signaling pathways via pertussis toxin-sensitive guanine nucleotide regulatory proteins.
Lai J; Waite SL; Bloom JW; Yamamura HI; Roeske WR
J Pharmacol Exp Ther; 1991 Sep; 258(3):938-44. PubMed ID: 1653846
[TBL] [Abstract][Full Text] [Related]
18. Neuropeptide Y inhibits forskolin-stimulated adenylate cyclase in bovine adrenal chromaffin cells via a pertussis toxin-sensitive process.
Zhu J; Li W; Toews ML; Hexum TD
J Pharmacol Exp Ther; 1992 Dec; 263(3):1479-86. PubMed ID: 1335068
[TBL] [Abstract][Full Text] [Related]
19. Cell-specific coupling of the cloned human 5-HT1F receptor to multiple signal transduction pathways.
Adham N; Borden LA; Schechter LE; Gustafson EL; Cochran TL; Vaysse PJ; Weinshank RL; Branchek TA
Naunyn Schmiedebergs Arch Pharmacol; 1993 Dec; 348(6):566-75. PubMed ID: 8133900
[TBL] [Abstract][Full Text] [Related]
20. Agonist-induced desensitization of D2 dopamine receptors in human Y-79 retinoblastoma cells.
Barton AC; Black LE; Sibley DR
Mol Pharmacol; 1991 May; 39(5):650-8. PubMed ID: 1674585
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
